BCI
REGN icon

Brinker Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Brinker Capital Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$987K Sell
1,582
-179
-10% -$122K 0.01% 1169
2026
Q1 		$1.36M Sell
1,761
-52
-3% -$39.8K 0.01% 949
2025
Q4 		$1.4M Sell
1,813
-90
-5% -$61.1K 0.01% 1049
2025
Q3 		$1.07M Buy
1,903
+399
+27% +$226K 0.01% 1190
2025
Q2 		$789K Sell
1,504
-326
-18% -$182K 0.01% 1318
2025
Q1 		$1.16M Sell
1,830
-252
-12% -$173K 0.01% 1002
2024
Q4 		$1.48M Sell
2,082
-489
-19% -$410K 0.01% 842
2024
Q3 		$2.7M Sell
2,571
-302
-11% -$336K 0.03% 542
2024
Q2 		$3.02M Buy
2,873
+138
+5% +$134K 0.03% 473
2024
Q1 		$2.63M Sell
2,735
-36
-1% -$34.2K 0.03% 528
2023
Q4 		$2.5M Sell
2,771
-12,934
-82% -$10.7M 0.03% 534
2023
Q3 		$12.9M Sell
15,705
-1,109
-7% -$872K 0.16% 138
2023
Q2 		$12.1M Sell
16,814
-458
-3% -$353K 0.13% 153
2023
Q1 		$14.2M Buy
17,272
+1,395
+9% +$1.05M 0.18% 122
2022
Q4 		$11.5M Sell
15,877
-4,121
-21% -$3.04M 0.23% 100
2022
Q3 		$13.8M Sell
19,998
-484
-2% -$305K 0.28% 82
2022
Q2 		$12.1M Sell
20,482
-179
-0.9% -$116K 0.23% 96
2022
Q1 		$14.4M Sell
20,661
-5,492
-21% -$3.47M 0.22% 101
2021
Q4 		$16.5M Sell
26,153
-8,011
-23% -$4.93M 0.24% 84
2021
Q3 		$19.1M Buy
34,164
+768
+2% +$477K 0.3% 74
2021
Q2 		$18.7M Buy
33,396
+5,741
+21% +$2.91M 0.25% 98
2021
Q1 		$13.1M Buy
+27,655
New +$13.5M 0.2% 126
2020
Q4 		– Sell
-13,676
Closed -$7.66M – 1162
2020
Q3 		$7.66M Buy
+13,676
New +$8.29M 0.13% 177
2020
Q1 		– Sell
-3
Closed -$1K – 649
2019
Q4 		$1K Buy
+3
New +$1.01K ﹤0.01% 782

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brinker Capital Investments's REGN Position: Q2 2026 in Review

Brinker Capital Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2026, selling an estimated $122K and leaving 1,582 shares worth $987K. The position accounts for 0.01% of the portfolio, ranked #1169.

Brinker Capital Investments first reported a position in REGN in Q4 2019 and has held it in 24 quarters since. The position peaked at $19.1M in Q3 2021. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Brinker Capital Investments held 1,582 shares of Regeneron Pharmaceuticals worth $987K as of Q2 2026.
  • Brinker Capital Investments sold 179 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $122K.
  • Regeneron Pharmaceuticals made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1169 holding.
  • Brinker Capital Investments first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 24 quarters since.
  • Brinker Capital Investments's Regeneron Pharmaceuticals position peaked at $19.1M in Q3 2021.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.